LIGAND PHARMACEUTICALS INC - COM NEW (LGND)

Q4 2017 13F Holders as of 12/31/2017

Type / Class
Equity / COM NEW
Number of holders
297
Total Shares
24.7M
Shares change
-182K
Total reported value, excl. options
$3.38B
Value change
-$24.7M
Put/Call ratio
2.62
Number of buys
145
Number of sells
-125
Price
$136.93
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.